WHO WE ARE

We are a newly formed private investment advisor, focused on investing in clinically advanced, innovative medicines.

We leverage our in-house knowledge and expertise in life sciences to provide a differentiated investment approach. Our firm is managed by a small group of executives with a track record of managing biotech businesses through drug discovery, development, and commercialization.
 
We are a long only fund, we avoid rumors and speculation. We are data driven and believe over time, true innovation will lead to significant price appreciation. We have a strong network of functional experts to help evaluate but also support the portfolio companies on their path to clinical and commercial success.